[1] Timens W,Kamps WA. Hemopoiesis in human fetal and embryonic liver. Microsc Res Tech,1997,39（5）:387-397.
[2] Nilsson SK,Bertoncello I. The development and establishment of hemopoiesis in fetal and newborn osteopetrotic（op/op） mice. Dev Biol,1994,164（2）:456-462.
[3] Orphanidou-Vlachou E,Tziakouri-Shiakalli C,Georgiades CS. Extramedullary hemopoiesis. Semin Ultrasound CT MR,2014,35（3）:255-262.
[4] 王利,唐承薇,王春晖,等. 发育过程中肝脏血管活性肠肽及其受体量的变化. 生理学报, 2005,57（3）:379-383.
[5] Rameshwar P,Gascon P,Oh HS,et al. Vasoactive intestinal peptide （VIP） inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Exp Hematol,2002,30（9）:1001-1009.
[6] Delgado M,Chorny A,Ganea D,et al. Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation. Ann NY Acad Sci,2006,1070:226-232.
[7] Yu Y,Wu RX,Gao LN,et al. Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli. Cell Adh Migr,2016,10（4）:342-359.
[8] Okada K,Kawao N,Yano M,et al. Stromal cell-derived factor-1 mediates changes of bone marrow stem cells during the bone repair process. Am J Physiol Endocrinol Metab,2016,310（1）:E15-23.
[9] Poggiogalle E,Donini LM,Lenzi A,et al. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle. World J Gastroenterol,2017,23（10）:1747-1757.
[10] Eshraghian A. Bone metabolism in non-alcoholic fatty liver disease:vitamin D status and bone mineral density. Minerva Endocrinol,2017,42（2）:164-172.
[11] Upala S,Jaruvongvanich V,Wijarnpreecha K,et al. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab,2016,（ahead of print）.
[12] Ikehara S. Role of hepatocyte growth factor in hemopoiesis. Leuk Lymphoma,1996,23（3-4）:297-303.
[13] Tari K,Atashi A,Kaviani S,et al. Erythropoietin induces production of hepatocyte growth factor from bone marrow mesenchymal stem cells in vitro. Biologicals,2017,45:15-19.
[14] Nita I,Hostettler K,Tamo L,et al. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells. Sci Rep,2017,7:41901.
[15] Solmesky LJ,Abekasis M,Bulvik S,et al. Bone morphogenetic protein signaling is involved in human mesenchymal stem cell survival in serum-free medium. Stem Cells Dev,2009,18（9）:1283-1292.
[16] Zachos T,Diggs A,Weisbrode S,et al. Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. Mol Ther,2007,15（8）:1543-1550.
[17] Al Ghrbawy NM,Afify RA,Dyaa N,et al. Differentiation of bone marrow:Derived mesenchymal stem cells into hepatocyte-like cells. Indian J Hematol Blood Transfus,2016,32（3）:276-283.
[18] Qu M,Yuan X,Liu D,et al. Bone marrow-derived mesenchymal stem cells attenuate immune-mediated liver injury and compromise virus control during acute hepatitis B virus infection in mice. Stem Cells Dev,2017,（ahead of print）.
[19] Haga H,Yan IK,Borelli D,et al. Extracellular vesicles from bone marrow derived mesenchymal stem cells protect against murine hepatic ischemia-reperfusion injury. Liver Transpl,2017,（ahead of print）.
[20] Haga H,Yan IK,Takahashi K,et al. Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med,2017,6（4）:1262-1272.
[21] Klein I,Cornejo JC,Polakos NK,et al. Kupffer cell heterogeneity:functional properties of bone marrow derived and sessile hepatic macrophages. Blood,2007,110（12）:4077-4085.
[22] Paradis K,Sharp HL,Vallera DA,et al. Kupffer cell engraftment across the major histocompatibility barrier in mice: bone marrow origin, class II antigen expression,and antigen-presenting capacity. J Pediatr Gastroenterol Nutr,1990,11（4）:525-533.
[23] Ikarashi M,Nakashima H,Kinoshita M,et al. Distinct development and functions of resident and recruited liver Kupffer cells/macrophages. J Leukoc Biol,2013,94（6）:1325-1336.
[24] Jamitzky S,Krueger AC,Janneschuetz S,et al. Insulin-like growth factor-1 receptor （IGF-1R） inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. Pediatr Blood Cancer,2015,62（11）:1979-1985.
[25] Ni F,Sun R,Fu B,et al. IGF-1 promotes the development and cytotoxic activity of human NK cells. Nat Commun,2013,4:1479. |
